VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,700 | -97.3% | 10,000 | -92.8% | 0.05% | -97.2% |
| Q2 2023 | $3,424,388 | +137.4% | 139,600 | +125.2% | 1.81% | +104.9% |
| Q1 2023 | $1,442,740 | +137.5% | 62,000 | +158.3% | 0.88% | +114.8% |
| Q4 2022 | $607,440 | -27.4% | 24,000 | +20.0% | 0.41% | +21.2% |
| Q4 2021 | $837,000 | -31.3% | 20,000 | -28.6% | 0.34% | -37.0% |
| Q3 2021 | $1,219,000 | +113.5% | 28,000 | +132.0% | 0.54% | +166.3% |
| Q2 2021 | $571,000 | +54.7% | 12,071 | +67.8% | 0.20% | +26.2% |
| Q1 2021 | $369,000 | -34.3% | 7,192 | -65.8% | 0.16% | -31.0% |
| Q4 2020 | $562,000 | -37.1% | 21,000 | -19.2% | 0.23% | -49.2% |
| Q3 2020 | $893,000 | +190.9% | 26,000 | +246.7% | 0.46% | +165.7% |
| Q2 2020 | $307,000 | – | 7,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |